98140-96-6 Usage
Uses
Used in Pharmaceutical Industry:
3-Pyridazinecarboxylic acid, 6-amino-, methyl ester (6CI, 9CI) is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and properties make it a valuable component in the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical industry, 3-Pyridazinecarboxylic acid, 6-amino-, methyl ester (6CI, 9CI) may be used as an intermediate in the synthesis of agrochemicals, such as pesticides and herbicides. Its potential applications in this field contribute to the development of more effective and environmentally friendly products.
Used in Organic Synthesis:
3-Pyridazinecarboxylic acid, 6-amino-, methyl ester (6CI, 9CI) is used as a key intermediate in the synthesis of other organic compounds. Its unique structure allows for various chemical reactions, making it a versatile building block in organic chemistry.
Used in Research and Development:
Due to its unique properties and potential applications, 3-Pyridazinecarboxylic acid, 6-amino-, methyl ester (6CI, 9CI) is used in research and development for exploring new chemical reactions, understanding its properties, and discovering new uses in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 98140-96-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,1,4 and 0 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 98140-96:
(7*9)+(6*8)+(5*1)+(4*4)+(3*0)+(2*9)+(1*6)=156
156 % 10 = 6
So 98140-96-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H7N3O2/c1-11-6(10)4-2-3-5(7)9-8-4/h2-3H,1H3,(H2,7,9)
98140-96-6Relevant academic research and scientific papers
Development of a Scalable Synthesis of the Small Molecule TGFβR1 Inhibitor BMS-986260
Vetrichelvan, Muthalagu,Rakshit, Souvik,Chandrasekaran, Sathishkumar,Chinnakalai, Karthikeyan,Darne, Chetan Padmakar,Doddalingappa, Dyamanna,Gopikumar, Indasi,Gupta, Anuradha,Gupta, Arun Kumar,Karmakar, Ananta,Lakshminarasimhan, Thirumalai,Leahy, David K.,Palani, Senthil,Radhakrishnan, Vignesh,Rampulla, Richard,Savarimuthu, Antony,Subramanian, Varadharajan,Velaparthi, Upender,Warrier, Jayakumar,Eastgate, Martin D.,Borzilleri, Robert M.,Mathur, Arvind,Vaidyanathan, Rajappa
, p. 1310 - 1320 (2020/07/24)
A scalable route to the small molecule TGFβR1 inhibitor BMS-986260 (1) was developed. This alternative approach circumvented the purification of intermediates by column chromatography and provided access to multikilogram quantities of the key intermediate
NAMPT INHIBITORS
-
Page/Page column 36, (2013/05/23)
Disclosed are compounds which inhibit the activity of NAMPT, compositions containing the compounds and methods of treating diseases during which NAMPT is expressed.
